Mounjaro Sales Skyrocket 502% as India's GLP-1 Market Thrives

Yo, peep this! Mounjaro, Eli Lilly's heavyweight champ in the diabetes and weight-loss ring, just flexed its sales to ₹1,256 crore in the last year, up 502%. With injectables takin' over the GLP-1 game, folks are lovin' the new vibes and higher doses, keepin' it smooth and fly, ya dig?